New technologies in clinical microbiology

Journal of Clinical Microbiology

Volumn 49, Issue 9 SUPPL., 2011, Pages

  Wolk, Donna M ^a   Dunne Jr , W Michael ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BLOOD CULTURE; BLOODSTREAM INFECTION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GRAM STAINING; HEALTH CARE COST; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL IDENTIFICATION; MICROBIOLOGY; MICROTECHNOLOGY; MYCOBACTERIOSIS; MYCOSIS; PARASITOSIS; PRIORITY JOURNAL; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SEPTIC SHOCK; TURNAROUND TIME; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; FUNGI;

EID: 80053213047     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00834-11     Document Type: Conference Paper

References (48)

1. Angus, D. C., et al. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-1310. (Pubitemid 32641789)
2. Anhalt, J. P., and C. Fenselau. 1975. Identification of bacteria using mass spectrometry. Anal. Chem. 47:219-225.
3. Barenfanger, J., C. Drake, and G. Kacich. 1999. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J. Clin. Microbiol. 37:1415-1418. (Pubitemid 29187810)
4. Barenfanger, J., et al. 2008. Decreased mortality associated with prompt Gram staining of blood cultures. Am. J. Clin. Pathol. 130:870-876.
5. Bauer, K. A., et al. 2010. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin. Infect. Dis. 51:1074-1080.
6. Bossuyt, P. M., et al. 2003. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem. 49:7-18. (Pubitemid 36078547)
7. Burchardi, H., and H. Schneider. 2004. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy. Pharmacoeconomics 22:793-813. (Pubitemid 39158998)
8. Centers for Disease Control and Prevention. 1990. Increase in national hospital discharge survey rates for septicemia - United States, 1979-1987. MMWR Morb. Mortal. Weekly Rep. 39:31-34.
9. Cherkaoui, A., et al. 2010. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J. Clin. Microbiol. 48:1169-1175.
10. Claydon, M. A., S. N. Davey, V. Edwards-Jones, and D. B. Gordon. 1996. The rapid identification of intact microorganisms using mass spectrometry. Nat. Biotechnol. 14:1584-1586. (Pubitemid 26365554)
11. Cribbs, S. K., and G. S. Martin. 2007. Expanding the global epidemiology of sepsis. Crit. Care Med. 35:2646-2648. (Pubitemid 351339034)
12. Danai, P., and G. S. Martin. 2005. Epidemiology of sepsis: recent advances. Curr. Infect. Dis. Rep. 7:329-334. (Pubitemid 41419366)
13. Dellinger, R. P., et al. 2008. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36:296-327.
14. Demirev, P. A., and C. Fenselau. 2008. Mass spectrometry in biodefense. J. Mass Spectrom. 43:1441-1457.
15. Doern, G. V., R. Vautour, M. Gaudet, and B. Levy. 1994. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32:1757-1762. (Pubitemid 24189570)
16. Ecker, D. J., et al. 2008. Ibis T5000: a universal biosensor approach for microbiology. Nat. Rev. Microbiol. 6:553-558. (Pubitemid 351850978)
17. Esper, A., and G. S. Martin. 2007. Is severe sepsis increasing in incidence and severity? Crit. Care Med. 35:1414-1415. (Pubitemid 46642675)
18. Fenollar, F., and D. Raoult. 2007. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int. J. Antimicrob. Agents 30(Suppl. 1):S7-S15.
19. Fenselau, C., and P. A. Demirev. 2001. Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom Rev. 20:157-171. (Pubitemid 34151741)
20. Ferreira, L., et al. 2010. Identification of Brucella by MALDI-TOF mass spectrometry. Fast and reliable identification from agar plates and blood cultures. PLoS One 5:e14235.
21. Forrest, G. N. 2007. PNA FISH: present and future impact on patient management. Expert. Rev. Mol. Diagn. 7:231-236. (Pubitemid 46804660)
22. Forrest, G. N., et al. 2006. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J. Clin. Microbiol. 44:3381-3383. (Pubitemid 44413783)
23. Forrest, G. N., et al. 2006. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J. Antimicrob. Chemother. 58:154-158. (Pubitemid 44294999)
24. Forrest, G. N., et al. 2008. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob. Agents Chemother. 52:3558-3563.
25. Garnacho-Montero, J., et al. 2003. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit. Care Med. 31:2742-2751. (Pubitemid 38010630)
26. Holland, R. D., et al. 1996. Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 10:1227-1232. (Pubitemid 26311530)
27. Holtzman, C., D. Whitney, T. Barlam, and N. S. Miller. 2011. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J. Clin. Microbiol. 49:1581-1582.
28. Hunfeld, K. P., T. Bingold, V. Brade, and H. Wissing. 2008. Molecular biological detection of pathogens in patients with sepsis. Potentials, limitations and perspectives. Anaesthesist 57:326-337. (In German.)
29. Jaeschke, R. Z., J. L. Brozek, and R. P. Dellinger. 2008. 2008 Update of international guidelines for the management of severe sepsis and septic shock: should we change our current clinical practice? Pol. Arch. Med. Wewn. 118:92-95. (Pubitemid 351488252)
30. Jordan, J. A., A. R. Butchko, and M. B. Durso. 2005. Use of pyrosequencing of 16S rRNA fragments to differentiate between bacteria responsible for neonatal sepsis. J. Mol. Diagn. 7:105-110. (Pubitemid 40310172)
31. Jordan, J. A., J. Jones-Laughner, and M. B. Durso. 2009. Utility of pyrosequencing in identifying bacteria directly from positive blood culture bottles. J. Clin. Microbiol. 47:368-372.
32. Kaleta, E. J., et al. 2011. Use of polymerase chain reaction coupled to electrospray ionization mass spectrometry for rapid identification of bacteria and yeast bloodstream pathogens from blood culture bottles. J. Clin. Microbiol. 49:345-353.
33. Kollef, M. H., G. Sherman, S. Ward, and V. J. Fraser. 1999. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462-474. (Pubitemid 29083057)
34. Kumar, A., et al. 2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34:1589-1596. (Pubitemid 43810035)
35. Lay, J. O., Jr. 2001. MALDI-TOF mass spectrometry of bacteria. Mass Spectrom Rev. 20:172-194.
36. Ly, T., J. Gulia, V. Pyrgos, M. Waga, and S. Shoham. 2008. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther. Clin. Risk Manag. 4:637-640. (Pubitemid 352037904)
37. Maier, T., and M. Kostrzewa. 2007. Fast and reliable MALDI-TOF MS-based microorganism identification. Chem. Today 25:68-71. (Pubitemid 46877543)
38. Marklein, G., et al. 2009. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47:2912-2917.
39. Moussaoui, W., et al. 2010. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials. Clin. Microbiol. Infect. 16:1631-1638.
40. Oliveira, K., et al. 2003. Direct identification of Staphylococcus aureus from positive blood culture bottles. J. Clin. Microbiol. 41:889-891. (Pubitemid 36184223)
41. Prod'hom, G., A. Bizzini, C. Durussel, J. Bille, and G. Greub. 2010. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J. Clin. Microbiol. 48:1481-1483.
42. Quiles-Melero, I., J. Garcia-Rodriguez, M. P. Romero-Gomez, P. Gomez-Sanchez, and J. Mingorance. 2011. Rapid identification of yeasts from positive blood culture bottles by pyrosequencing. Eur. J. Clin. Microbiol. Infect. Dis. 30:21-24.
43. Sampath, R., et al. 2007. Global surveillance of emerging Influenza virus genotypes by mass spectrometry. PLoS One 2:e489.
44. Stevenson, L. G., S. K. Drake, and P. R. Murray. 2010. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48:444-447.
45. Valles, J., et al. 2008. Bloodstream infections in adults: importance of healthcare-associated infections. J. Infect. 56:27-34. (Pubitemid 350253652)
46. Wellinghausen, N., et al. 2009. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J. Clin. Microbiol. 47:2759-2765.
47. Westh, H., et al. 2009. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin. Microbiol. Infect. 15:544-551.
48. Wolk, D. M., et al. 2009. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J. Clin. Microbiol. 47:823-826.